1014P Phase Ib trial results of safety, pharmacokinetics and pharmacodynamics of TU2218, TGFβ-RI and VEGF-R2 dual inhibitor in combination with pembrolizumab in patients with advanced solid tumors
| Autor: | Tolcher, A.W., Kim, H-T., Oh, D-Y., Kim, K-P., Chaudhry, A., Chaney, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S687-S687 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|